Drug
Montelukast 10 Mg Oral Tablet
Montelukast 10 Mg Oral Tablet is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_2
2
50%
Ph phase_3
1
25%
Ph early_phase_1
1
25%
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Not yet recruiting2
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)
Trials by Status
recruiting125%
not_yet_recruiting250%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction
NCT07537868
completedphase_2
Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions
NCT04198623
not_yet_recruitingearly_phase_1
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
NCT06887673
not_yet_recruitingphase_3
Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast
NCT06340984
Clinical Trials (4)
Showing 4 of 4 trials
NCT07537868Phase 2
Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction
NCT04198623Phase 2
Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions
NCT06887673Early Phase 1
Lipid Mediators & Cancer: Montelukast, SPM, and Almonds
NCT06340984Phase 3
Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of Montelukast
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4